TECX · Tectonic Therapeutic, Inc.
$22.54
-0.13 (-0.57%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$462.73M
Shares
19.55M
Volume · Oct 2
253.43K
Avg daily vol (3M)
221.58K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$22.54
Open$22.73
Day$22.14–23.07
52W close$14.91–37.93
Avg vol 30d242K
Short int2.2M · 11.3% float · 13.0d
Short vol37%
Last earningsFeb 24, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$85.79M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-15.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.5%
Year over year · more shares
Price change (1Y)
+47.8%
Trailing year
Short interest
11.3%
Latest settlement · 13.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
−25%
below
RSI (14)
25
oversold
MACD trend
Negative
52-week position
33%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−25%
trailing
6-month return
−25%
trailing
YTD return
+8%
this year
Relative strength
−37%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $30 › 200d $28 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +22 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
11.35% of float · ▲ +14.2% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
123 holders — near 3-yr high, broad support
Squeeze score
76
high risk · 0–100
Fundamentals
EPS growth
+41%
Y/Y
Free cash flow
$-60.3M
Balance sheet
$77.6M
net cash
Quant / Vol
risk profile
Volatility
75%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
7.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
−25%
Bearish
RSI (14)
25
Neutral
MACD trend
Negative
Bearish
52-week position
33%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $30 › 200d $28 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +22 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
11.35% of float · ▲ +14.2% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
123 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $15
Now $23 · 33%
Range high $38
vs 200-day avg -19%
vs 50-day avg -25%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TECX
this stock
Tectonic Therapeutic, Inc.
|
$462.73M | +8.1% | — | — | 11.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.3% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -4.8% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +544.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TECX | -4.8% | -24.7% | -24.8% | -3.2% | +8.1% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -4.6% | -24.2% | -37.0% | -4.1% | -4.8% |